AP2869A - Electroporation of mycobacterium and overexpression of antigens in mycobacteria - Google Patents

Electroporation of mycobacterium and overexpression of antigens in mycobacteria

Info

Publication number
AP2869A
AP2869A AP2007004021A AP2007004021A AP2869A AP 2869 A AP2869 A AP 2869A AP 2007004021 A AP2007004021 A AP 2007004021A AP 2007004021 A AP2007004021 A AP 2007004021A AP 2869 A AP2869 A AP 2869A
Authority
AP
ARIPO
Prior art keywords
mycobacteria
mycobacterium
overexpression
electroporation
antigens
Prior art date
Application number
AP2007004021A
Other languages
English (en)
Other versions
AP2007004021A0 (en
Inventor
David Michael Hone
Jerald C Sadoff
Ronggai Sun
Original Assignee
Aeras Global Tb Vaccine Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aeras Global Tb Vaccine Found filed Critical Aeras Global Tb Vaccine Found
Publication of AP2007004021A0 publication Critical patent/AP2007004021A0/xx
Application granted granted Critical
Publication of AP2869A publication Critical patent/AP2869A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AP2007004021A 2004-12-01 2005-11-29 Electroporation of mycobacterium and overexpression of antigens in mycobacteria AP2869A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63197704P 2004-12-01 2004-12-01
PCT/US2005/042976 WO2006060332A2 (fr) 2004-12-01 2005-11-29 Electroporation of mycobacterium et surexpression d'antigenes dans des mycobacteries

Publications (2)

Publication Number Publication Date
AP2007004021A0 AP2007004021A0 (en) 2007-06-30
AP2869A true AP2869A (en) 2014-03-31

Family

ID=36565595

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004021A AP2869A (en) 2004-12-01 2005-11-29 Electroporation of mycobacterium and overexpression of antigens in mycobacteria

Country Status (16)

Country Link
US (1) US7625572B2 (fr)
EP (1) EP1817061B1 (fr)
JP (1) JP5461776B2 (fr)
KR (1) KR101382215B1 (fr)
CN (1) CN101076356B (fr)
AP (1) AP2869A (fr)
AT (1) ATE517637T1 (fr)
AU (1) AU2005312062B2 (fr)
BR (1) BRPI0518080A (fr)
CA (1) CA2587507C (fr)
DK (1) DK1817061T3 (fr)
EA (1) EA012182B1 (fr)
ES (1) ES2370885T3 (fr)
MX (1) MX2007006552A (fr)
WO (1) WO2006060332A2 (fr)
ZA (1) ZA200704764B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101329323B1 (ko) * 2004-12-01 2013-11-14 아에라스 글로벌 티비 백신 파운데이션 엔도솜을 이탈하는 능력이 보강된 재조합 비씨지 균주
US7829104B2 (en) * 2004-12-01 2010-11-09 Aeras Global Tb Vaccine Foundation Electroporation of Mycobacterium and overexpression of antigens in mycobacteria
US20110172826A1 (en) * 2005-12-14 2011-07-14 Amodei Dario G Device including altered microorganisms, and methods and systems of use
US8278094B2 (en) 2005-12-14 2012-10-02 The Invention Science Fund I, Llc Bone semi-permeable device
US8734823B2 (en) * 2005-12-14 2014-05-27 The Invention Science Fund I, Llc Device including altered microorganisms, and methods and systems of use
US8682619B2 (en) * 2005-12-14 2014-03-25 The Invention Science Fund I, Llc Device including altered microorganisms, and methods and systems of use
US20110183348A1 (en) * 2010-01-22 2011-07-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with microorganisms
WO2007079351A2 (fr) * 2005-12-15 2007-07-12 Aeras Global Tb Vaccine Foundation Nouvelles combinaisons de primo-immunisation/rappel d'une mycobacterie attenuee
US8932846B2 (en) * 2007-06-14 2015-01-13 The Regents Of The University Of California Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins
JP2015513915A (ja) * 2012-04-02 2015-05-18 アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティＡｒｉｚｏｎａ Ｂｏａｒｄ Ｏｆ Ｒｅｇｅｎｔｓ Ｆｏｒ Ａｎｄ Ｏｎ Ｂｅｈａｌｆ Ｏｆ Ａｒｉｚｏｎａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ 細胞性免疫応答の誘導のための組換え細菌
US9926346B2 (en) 2012-04-16 2018-03-27 Aeras Recombinant mycobacterium encoding a heparin-binding hemagglutinin (HBHA) fusion protein and uses thereof
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN118221791A (zh) * 2024-05-23 2024-06-21 山东第二医科大学 一种Rv0653c蛋白、其抗体及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736367A (en) * 1992-03-31 1998-04-07 Medimmune, Inc. Vectors and prokaryotes which autocatalytically delete antibiotic resistance
US6423545B1 (en) * 1999-07-08 2002-07-23 Albert Einstein College Of Medicine Of Yeshiva University Unmarked deletion mutants of mycobacteria and methods of using same
US6562348B2 (en) * 1999-07-08 2003-05-13 Albert Einstein College Of Medicine Of Yeshiva University Recombinant M. tuberculosis auxotrophic for leucine and vaccines using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783386A (en) * 1994-02-24 1998-07-21 Agresearch, New Zealand Pastoral Agriculture Research Institute Ltd. Mycobacteria virulence factors and a novel method for their identification
EP0745386B1 (fr) * 1994-07-29 2004-02-04 Ajinomoto Co., Inc. Vaccin b.c.g. de recombinaison secretoire contre le sida
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US6004815A (en) * 1998-08-13 1999-12-21 The Regents Of The University Of California Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
CN1342771A (zh) * 2001-09-17 2002-04-03 复旦大学 结核分枝杆菌Ag85B抗原的表达纯化和作为疫苗组份的应用
WO2006072787A1 (fr) * 2005-01-05 2006-07-13 Isis Innovation Limited Compositions permettant d'immuniser contre mycobacterium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736367A (en) * 1992-03-31 1998-04-07 Medimmune, Inc. Vectors and prokaryotes which autocatalytically delete antibiotic resistance
US6423545B1 (en) * 1999-07-08 2002-07-23 Albert Einstein College Of Medicine Of Yeshiva University Unmarked deletion mutants of mycobacteria and methods of using same
US6562348B2 (en) * 1999-07-08 2003-05-13 Albert Einstein College Of Medicine Of Yeshiva University Recombinant M. tuberculosis auxotrophic for leucine and vaccines using same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BAULARD A ET AL: "A new series of mycobacterial expression vectors for the development of live recombinant vaccines." GENE 17 OCT 1996, vol. 176, no. 1-2, 17 October 1996 (1996-10-17), pages 149-154 *
MCSHANE H ET AL: "Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans" NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 10, no. 11, 24 October 2004 (2004-10-24), pages 1240-1244 *
SNAPPER, S.B. et al. Lysogeny and transformation in mycobacteria: Stable experession of foreign genes. Proc. Nat. Acad. Sci. USA, September 1988, vol. 85, pages 6987-6991 *

Also Published As

Publication number Publication date
EP1817061A4 (fr) 2009-07-08
US7625572B2 (en) 2009-12-01
EP1817061A2 (fr) 2007-08-15
CN101076356A (zh) 2007-11-21
KR20070111452A (ko) 2007-11-21
ZA200704764B (en) 2008-09-25
WO2006060332A3 (fr) 2006-08-03
ES2370885T3 (es) 2011-12-23
AU2005312062B2 (en) 2011-11-17
JP5461776B2 (ja) 2014-04-02
JP2008521435A (ja) 2008-06-26
AP2007004021A0 (en) 2007-06-30
ATE517637T1 (de) 2011-08-15
EP1817061B1 (fr) 2011-07-27
US20060121054A1 (en) 2006-06-08
MX2007006552A (es) 2007-08-20
KR101382215B1 (ko) 2014-04-08
CA2587507A1 (fr) 2006-06-08
BRPI0518080A (pt) 2008-10-28
AU2005312062A1 (en) 2006-06-08
DK1817061T3 (da) 2011-11-14
CN101076356B (zh) 2013-04-03
WO2006060332A2 (fr) 2006-06-08
CA2587507C (fr) 2013-11-19
EA200701130A1 (ru) 2007-12-28
EA012182B1 (ru) 2009-08-28

Similar Documents

Publication Publication Date Title
AP2869A (en) Electroporation of mycobacterium and overexpression of antigens in mycobacteria
EP1885859A4 (fr) Electroporation et transfert de masse régulés à travers les membranes cellulaires des tissus
EP1781313A4 (fr) Epitopes de mycobacterium tuberculosis et leurs procedes d'utilisation
EP1765988A4 (fr) Cellules de presentation de nouveaux antigenes artificiels, et utilisations correspondantes
PT2066399T (pt) Dispositivos de eletroporação e métodos de usar os mesmos para eletroporação de células em mamíferos
IL183458A0 (en) Anti-il-1r1 single domain antibodies and therapeutic uses
IL178593A (en) Specific antibodies of fcγriib and methods for their use
IL177587A0 (en) Batteries and methods of manufacture and uses thereof
IL213843A0 (en) 4-aminotetracyclines and methods of use thereof
GB0605702D0 (en) Materials and methods for immune cell stimulation
EP1729798A4 (fr) Therapie utilisant des lymphocytes t specifiques aux antigenes
EP1909644A4 (fr) Appareil d'insertion et procédés d'utilisation
EP1909097A4 (fr) Biocapteur et cellule à biocapteur
EP1740210A4 (fr) Anticorps irta-5 et utilisations de ces derniers
GB0522952D0 (en) Cover skin with high and low gloss
EP1597390A4 (fr) Introduction d'antigenes dans des cellules par electroporation
EP1838288A4 (fr) Materiels et procedes therapeutiques
IL177464A0 (en) Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
GB2416543B (en) Cell culture device and manufacturing method thereof
EP1940507A4 (fr) Dispositif iontophoretique intraoculaire, et procedes associes
GB0426182D0 (en) Photoporation of cells
GB0615267D0 (en) Shallow trench isolation process and structure
GB0407382D0 (en) Therapeutic methods and means
SG115828A1 (en) Fluid-ejection device and methods of forming same
GB0424552D0 (en) Methods and means